CCT4 and cancer: Among the 21 selected CTAs, GAGE2, CT45, CCT4, and PRAME cancer/testis antigens were revealed to be correlated with the prognosis for ovarian cancer patients, and GAGE2, CCT4, and PRAME were identified for the first time.